Step 1: Book
Book a visit with a doctor to discuss your Mounjaro® prescription.
Mounjaro® (tirzepatide) prescription online
Mounjaro® (tirzepatide) is an injectable prescription to treat type 2 diabetes that is highly effective in improving blood sugar levels in adults with type 2 diabetes. Additional benefits may include weight loss. Speak to one of our trusted, board-certified doctors about how Mounjaro® could be right for you.
Improves the release of insulinReduces appetite and increases fullnessOnly taken once a week
*Mounjaro® is not a weight loss drug. Your doctor may recommend Mounjaro® based on your eligibility and its current availability. Please note that in the event of a national shortage in which Mounjaro® is commercially unavailable according to the FDA, your physician may recommend an alternative treatment option.
3 simple steps to discuss your Mounjaro® prescription
Step 2: Chat
Discuss treatment options with your doctor and complete your medical evaluation.
Step 3: Pick up
Pick up your medication from your pharmacy, if prescribed.
What is Mounjaro® (tirzepatide), and how does it work?
Mounjaro® (tirzepatide) is an injectable prescription to treat type 2 diabetes with additional benefits that may include weight loss. If you're seeking a prescription for Mounjaro® online, our team of professional online doctors is available to assist you.
If you're currently dealing with type 2 diabetes, Mounjaro® can help you control your blood sugar levels by increasing insulin production and lowering the amount of sugar your liver makes. It also can slow down the rate at which food passes through your body and reduce your appetite. This can help you feel fuller for longer.
Consult with one of our respected, board-certified doctors to explore whether Mounjaro® might be the appropriate option for you. If you're among the countless individuals curious about obtaining Mounjaro® for type 2 diabetes, rest assured that our doctors possess specialized expertise in prescribing Mounjaro® or suggesting alternative treatments tailored to your unique health background.
If you're currently dealing with type 2 diabetes, Mounjaro® can help you control your blood sugar levels by increasing insulin production and lowering the amount of sugar your liver makes. It also can slow down the rate at which food passes through your body and reduce your appetite. This can help you feel fuller for longer.
Consult with one of our respected, board-certified doctors to explore whether Mounjaro® might be the appropriate option for you. If you're among the countless individuals curious about obtaining Mounjaro® for type 2 diabetes, rest assured that our doctors possess specialized expertise in prescribing Mounjaro® or suggesting alternative treatments tailored to your unique health background.
Mounjaro® uses
Type 2 diabetes
Mounjaro® (tirzepatide) is FDA-approved to treat type 2 diabetes. According to SURPASS-2 clinical trials, it has shown to be very effective in treating type 2 diabetes, especially compared to other drugs on the market, such as semaglutide. It has also shown to be an effective alternative option when other medications, including Janumet, do not provide sufficient glycemic control.
Although Mounjaro® is not FDA-approved for weight loss, it has been found to cause significant weight loss. Tirzepatide for weight loss is now available under the brand name Zepbound®. Based on the SURMOUNT-1 clinical trial results, Zepbound® will likely become the most effective weight loss drug available.
While Mounjaro® (tirzepatide) is an excellent option for many, we believe in shedding light on alternative medications, ensuring accessibility to the most fitting treatment. Considering availability and individual preferences, our physicians may propose or prescribe another GLP-1 for effective type 2 diabetes management. Here's a glance at these GLP-1 options:
Compounded tirzepatide: During the recent FDA shortages, compounded tirzepatide was prescribed as an alternative to branded Mounjaro®. When Mounjaro ® is on the FDA drug shortages list, compounded tirzepatide may be prescribed, but when it is not on the FDA drug shortage list, it cannot be prescribed. While compounded tirzepatide is not FDA-approved, our preferred pharmacy provider adheres to all relevant federal and state regulations and FDA guidelines.*
Other medication treatment options
Ozempic® (semaglutide): Ozempic® comes in a once-weekly injectable format. Beyond reliability and efficiency in blood sugar management, it offers the added benefit of reducing cardiovascular risk, enhancing its appeal.
Semaglutide: Due to shortages, compounded semaglutide may be prescribed as an alternative to branded Ozempic® as long as it remains on the FDA drug shortages list. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with pertinent federal and state laws and FDA regulations.*
Rybelsus® (semaglutide): Rybelsus® is an oral GLP-1 medication, ideal for those favoring a pill over injections. However, injectable semaglutide has a higher range of doses for those who need benefits beyond what oral semaglutide can provide.
Trulicity® (dulaglutide): Recognized for its user-friendly design, Trulicity® offers a once-weekly injection experience with a pre-filled, disposable pen.
Victoza® (liraglutide): Victoza® is a daily injectable for diabetes management. Its daily regimen suits individuals looking for a consistent, day-to-day approach to their treatment.
Bydureon® (exenatide): Bydureon® provides another option for once-a-week injection treatment.
*Availability for compounded semaglutide and tirzepatide is limited to residents in the following states: AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, VA, VT, WA, WI, WV, Washington D.C., WY.
Although compounded semaglutide and tirzepatide are not FDA-approved, our pharmacy provider complies with all federal and state laws and FDA regulations.
How pricing works
Become a member and get access to GLP-1 medications, insurance support, doctor-led guidance, and metabolic testing; on top of access to all of PlushCare's primary care services
30 days of free membership
- Same-day appointments 7 days a week
- Unlimited messages with your Care Team
- Exclusive discounts on lab tests
- Free memberships for your family
- Cancel anytime
Paying with insurance
Membership
$19.99 /month
First month free
+
Visits
Copay
Visit price with insurance
Often the same as an office visit. Most patients with in-network insurance pay $30 or less! We accept these insurance plans and many more:
Paying without insurance
Membership
$19.99 /month
First month free
+
Visits
$129
Visit price without insurance
Initial visits are $129.
*If we're unable to treat you, we'll provide a full refund. Please note that any medication or lab work costs are not included. Please refer to our refund policy for additional information.
Mounjaro® ratings and reviews
5
As a corporate benefits executive for a Fortune 500 company, I am typically a skeptical of membership telehealth providers. Even some of the ones affiliated with major carriers are still "learning". My experience with PlushCare was absolutely stellar from the technology, efficiency, quality of care and follow-up perspective. While this was just one event, I am extremely impressed and will not hesitate to use the services again when needed.
D.M.
Sept. 2022
Read review5
Great app, great Doctors! There are DR's available nearly 24/7 for appointments. Even between 12am-6am. My doctor is friendly and knowledgeable and quickly built a plan with me to accomplish some of my health goals. Were easy to talk to when I wanted to try the new weight loss medication that was FDA approved. Got the prescription in 2 visits (4 days) once I got some blood work done. Love Plush Care!
Y.C.
Mar, 2022
5
When my assigned physician went sideways in treating my diabetes contacted PlushCare and got Dr Jar who was a diabetes doctor that addressed my needs.
L.W.
Feb, 2022
5
As a corporate benefits executive for a Fortune 500 company, I am typically a skeptical of membership telehealth providers. Even some of the ones affiliated with major carriers are still "learning". My experience with PlushCare was absolutely stellar from the technology, efficiency, quality of care and follow-up perspective. While this was just one event, I am extremely impressed and will not hesitate to use the services again when needed.
D.M.
Sept. 2022
Read review5
Great app, great Doctors! There are DR's available nearly 24/7 for appointments. Even between 12am-6am. My doctor is friendly and knowledgeable and quickly built a plan with me to accomplish some of my health goals. Were easy to talk to when I wanted to try the new weight loss medication that was FDA approved. Got the prescription in 2 visits (4 days) once I got some blood work done. Love Plush Care!
Y.C.
Mar, 2022
5
When my assigned physician went sideways in treating my diabetes contacted PlushCare and got Dr Jar who was a diabetes doctor that addressed my needs.
L.W.
Feb, 2022
Anticipated Mounjaro® side effects
The safety and tolerability profile for tirzepatide is felt to be similar to other related diabetes medicines such as semaglutide and liraglutide. Mounjaro® side effects would include:
Prescription nausea medication
Diarrhea
Constipation
Vomiting
Additional study is ongoing and looking closely for other unanticipated adverse effects. As of yet, there is no long-term safety data on this drug.
If you experience a serious allergic reaction, seek emergency medical attention immediately.
What are the pros and cons?
Mounjaro®
Pros
-
Improves blood sugar, with average 2.3% reduction in HA1C
-
Average loss of 15% of body weight when combined with diet and exercise
-
Reduces appetite and improves insulin resistance
-
Works great with low-carb, high-protein diets
Cons
-
No long-term safety data yet
-
Gastrointestinal side effects are commonly reported
-
May cause reactions at injection site
-
Regular monitoring of kidney function is needed
Mounjaro® prescription FAQs
- How can I get Mounjaro® online for weight loss?It is essential to know that Mounjaro® is only FDA-approved to treat type 2 diabetes and lower A1c levels. However, Zepbound® is the new version of tirzepatide FDA-approved for weight loss.
If you have type 2 diabetes, a BMI of at least 27, and are struggling with weight loss, speak to a board-certified doctor to begin the evaluation process and complete any necessary lab tests. Book an online appointment with one of our board-certified doctors to discuss if you can qualify for Mounjaro® and begin the evaluation process. - How do you qualify for Mounjaro®?Mounjaro® is a type 2 diabetes drug that can also help with weight loss. If you have diabetes and are struggling with weight loss, speak with one of our trusted, board-certified physicians online to discuss your health concerns and start the evaluation process for Mounjaro®. This would include discussing your medical history and current medication and ordering baseline tests and studies to determine if you qualify for a Mounjaro® prescription.
Wegovy® and Zepbound™ are extremely effective for weight loss. They have been approved for weight loss only and not type 2 diabetes. Speak to one of our trusted, board-certified doctors about how Wegovy® or Zepbound™ could be right for you. - Can I get a Mounjaro® prescription online?You may be able to get a Mounjaro® prescription online after meeting with a doctor to discuss your medical history and complete any necessary evaluations and labwork.
You can begin the evaluation process for Mounjaro® online with one of our board-certified doctors. If you have diabetes and are seeking weight management options, book an appointment with one of our top-rated doctors online. After ordering any necessary lab tests and reviewing your results, your doctor can electronically send a prescription to your local or mail-order pharmacy if you qualify. - How does Mounjaro® work for weight loss?Although Mounjaro® is only approved to treat type 2 diabetes, Mounjaro® can help promote weight loss by reducing hunger and slowing digestion.
- Is Mounjaro® approved for weight loss?
Although Mounjaro® can promote weight loss, it has only been FDA-approved to treat type 2 diabetes.
- How does Mounjaro® work?
Tirzepatide is what is known as a “dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist.” This long and complicated name means it can do two things:
-
Stimulate GLP-1 receptors in the body to both help control blood sugar and reduce hunger, promoting weight loss.
-
Promote release of glucose-dependent insulinotropic polypeptide which helps modulate levels of a hormone called glucagon and improve insulin sensitivity of adipose (fat) tissue.
-
- Is Mounjaro® the same as Ozempic®?Mounjaro® and Ozempic® are in the same class of drugs but work via different mechanisms. Mounjaro® works on GIP and GLP-1 receptors, while Ozempic® only works on GLP-1 receptors. Both are used to treat type 2 diabetes and can promote weight loss. To find out which is right for you, schedule a telehealth appointment with one of our board-certified doctors.
- How much does Mounjaro ® cost?Your monthly cost may vary if you qualify for a Mounjaro® prescription, and the drug is included in your insurance plan’s formulary. Most branded type 2 diabetes and weight loss medications require prior authorization for insurance to cover the cost. Your PlushCare physician and care team will reach out to your insurer on your behalf, and this process can take several business days. Your physician and our care team will reach out to your insurer on your behalf, and this process can take several business days. If you are denied the prior authorization or do not have health insurance, you may still purchase the medication at the total cash price. It is important to note that a type 2 diabetes diagnosis is usually required for insurance approval of this medication.
The makers of tirzepatide/Mounjaro® (Lilly) are currently offering a co-pay savings card of $25 per month for specific individuals who qualify, which can be found on their website. Unfortunately, Mounjaro® is expensive without insurance, ranging around $1000/month, depending on the pharmacy. - Am I eligible for the Mounjaro® Savings Card?A limited number of patients may be eligible for the Mounjaro® Saving Card, which allows certain patients to pay as little as $25 for a one-month or three-month supply of Mounjaro®. You will likely need a type 2 diabetes diagnosis for eligibility. To find out if you are eligible, complete the enrollment form on the Mounjaro® website.
- What does Mounjaro® do to your body?Mounjaro® helps control blood sugar and reduce hunger by releasing more insulin and less sugar and slowing down digestion. This helps treat diabetes and can promote weight loss.
- Can I get tirzepatide yet?Production and distribution of tirzepatide to pharmacies began in June 2022, but there is limited availability.
- What have been the results of the Mounjaro® clinical trials?A study published in 2021 called SURPASS-2 on over 1800 participants found that Mounjaro® (tirzepatide) + metformin was superior to semaglutide +metformin on reduction in Hemoglobin A1C in individuals with Type 2 Diabetes. When evaluating tirzepatide vs. semaglutide as a secondary endpoint, 5.5% more weight loss was noted in the tirzepatide group compared to the semaglutide group.1
The most recent clinical trial, SURMOUNT-1, reports that the average weight loss among over 2500 trial participants was 16% at 72 weeks.2 Adults randomly assigned to receive tirzepatide had average weight losses of 16% with 5 mg of the drug, 21.4% with 10 mg, and 22.5% with 15 mg, compared with only 2.4% weight loss with participants who took a placebo. Of the tirzepatide group, 89% achieved a weight loss of at least 5% compared with 28% in the placebo group. The average BMI of trial participants starting was 38 and was reduced to an average of 30, with many subjects getting into the normal range. - How does Mounjaro® compare to similar weight loss medications or surgery?Keep in mind that currently Mounjaro® (tirzepatide) is not technically FDA-approved for weight loss, but to treat diabetes. But based on the results of SURMOUNT-1, if Mounjaro® was approved for weight loss, it would easily become the most effective drug available. Given that it has two different mechanisms of action, it appears to have a greater effect on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, which are both currently FDA approved for sugar and weight control under different trade names. So when comparing tirzepatide vs. semaglutide, liraglutide, or other diabetes medicines, it seems to be much more effective.
Given that over half the patients on the 10 mg dose and 63% of those on the 15 mg dose lost more than 20% of their body weight, this number takes many past the weight loss achieved long term with surgical interventions such as the lap-band, and is within the typical ranges achieved long term with procedures such as the sleeve gastrectomy.